Navigation Links
Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
Date:3/3/2008

SEATTLE, March 3 /PRNewswire-FirstCall/-- Dendreon Corporation (Nasdaq: DNDN) announced the publication of a manuscript titled, "CD54 is a surrogate marker of antigen presenting cell activation" in Cancer Immunology, Immunotherapy.

The manuscript describes and supports the use of CD54 as a surrogate marker of antigen presenting cell activation (APC) activation and validates its utility as a potency measure of PROVENGE(R) (sipuleucel-T). In particular, it describes how Dendreon researchers used CD54 and the upregulation of its expression on antigen presenting cells (APC) as a means by which human APC activation could be assessed and most importantly, how such measurements could be used to determine the potency of PROVENGE before its administration to patients with prostate cancer. The assessment of product potency is a key release measure required by the U.S. Food and Drug Administration (FDA).

The upregulation of CD54 has been used as part of the potency assay for PROVENGE since the initiation of the PROVENGE clinical development program. Data correlating CD54 upregulation to overall survival in patients from two Phase 3 trials, D9901 and D9902A have been presented at recent scientific meetings and at the FDA Cell Tissue and Gene Therapy Advisory Committee Meeting on March 29, 2007.

About Active Cellular Immunotherapy with PROVENGE

PROVENGE may represent the first product in a new class of active cellular immunotherapies (ACIs) that are uniquely designed to use live human cells to engage the patient's own immune system with the goal of eliciting a specific long-lasting response against cancer. In clinical studies, patients typically received three doses of PROVENGE over a one-month period as a complete course of therapy.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports Third Quarter 2007 Financial Results
6. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
9. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
10. Consortium publishes Phase II map of human genetic variation
11. The Lancet Publishes Vasogens ACCLAIM Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... matter physicist, vanadium oxide (VO2) may be the coolest material ... It,s a window coating and an optical switch. And thanks ... have a new way to reversibly alter VO2,s electronic properties ... hydrogen. , So what is VO2? It,s an oxidized form ... oxygen reacts with vanadium to form VO2, the atoms form ...
(Date:5/21/2012)... 2012 Elsevier,s Computers & Graphics announces ... Object Retrieval which will incorporate the Collage Authoring Environment, ... place winner of the 2011 Executable Paper Grand Challenge. ... announced at Eurographics 2012 on May 13, during the ... the ability to embed chunks of executable code and ...
(Date:5/21/2012)... TALLAHASSEE, Fla., May 21, 2012  The ... more than 1,800 urologists, today discredited recommendations by ... stop prostate cancer testing. USPSTF,s final ... men from having the PSA test. This comes ... and patient advocacy groups, all who have confirmed ...
(Date:5/21/2012)... 21, 2012 The Houston Technology ... accelerator, hosted its 9th annual gala, "A ... local entrepreneurs that have made a significant impact ... revolutionary technologies. The Houston Technology Center ... as this year,s honoree. As the Founder and CEO ...
Breaking Biology Technology:Reversible doping: Hydrogen flips switch on vanadium oxide 2Reversible doping: Hydrogen flips switch on vanadium oxide 3Urologists Outraged over Government Panel's Recommendation to Stop Life-Saving Prostate Cancer Testing 2Urologists Outraged over Government Panel's Recommendation to Stop Life-Saving Prostate Cancer Testing 3Leading Technology Incubator Honors Extraordinary Entrepreneurs 2Leading Technology Incubator Honors Extraordinary Entrepreneurs 3
... last week to chat with a protester whose sign read: ... and pleasant enough guy just caught up in his ... last, best hope for the worlds poorest farmers, not to ... enough to eat because drought, disease, worn-out soils, harsh growing ...
... Esker has announced a service it claims will eliminate ... regular communications such as invoices or orders, companies can buy ... their own equipment or, in the case of faxes, phone ... like a metered service in order to save money and ...
... Editors Note: Dr. Jeffrey Grossman, president and CEO ... dean for clinical affairs for UW Medical School was ... In this interview with WTN, Dr. Grossman discusses how ... but, at the same time a Knowledge Gap between ...
Other Biology Technology:The New Green Revolution offers hope to poor farmers and poor consumers 2The New Green Revolution offers hope to poor farmers and poor consumers 3WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 2WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 3WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 4WTN interview: Dr. Jeffrey Grossman, CEO UW Medical Foundation 5
(Date:5/21/2012)... Florida Institute of Technology professor of biological sciences, ... National Science Foundation for research into the potential ... quantitative approaches to assess the clustering of infectious ... corals. When diseases cluster they are usually contagious; ... of infection., Although diseases are one of the ...
(Date:5/21/2012)... from the National University of Singapore,s (NUS) Department of ... drug-led compound a compound that is undergoing preclinical ... cells of energy and stop them from growing into ... , This is the first time a research group ... tumour formation. , Building on the new findings, ...
(Date:5/21/2012)... student from CSIRO and the University of Queensland has ... The student, Lauren Bragg, has contributed to the May ... highlighting her new approach and its software implementation called ... sequencing instruments which read the four-letter alphabet of As, ... for DNA and spell out the genes of different ...
Breaking Biology News(10 mins):Novel discovery by NUS scientists paves the way for more effective treatment of cancers 2New approach to 'spell checking' gene sequences 2Ritas Squeezes Pediatric Cancer with 24451 000 Donation 53226 1Ritas Squeezes Pediatric Cancer with 24451 000 Donation 53226 2Ritas Squeezes Pediatric Cancer with 24451 000 Donation 53226 3Douglas fir geoducks make strange bedfellows in studying climate change 9425 1Douglas fir geoducks make strange bedfellows in studying climate change 9425 2Douglas fir geoducks make strange bedfellows in studying climate change 9425 3Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillions Clinical Workstation Solution 53221 1Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillions Clinical Workstation Solution 53221 2Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillions Clinical Workstation Solution 53221 3
... champions of organ regrowth because they direct their wound ... published in the online open access journal, BMC Developmental ... mechanisms during wound healing and organ regeneration gives us ... wounds and, perhaps eventually, how to regenerate body parts. ...
... University and the University of Bucharest, Romania, have ... in eastern Romania. Previously unexamined, these ancient crabs ... million years ago during the Jurassic period. ... various aspects of biodiversity and patterns of evolution, ...
... Have you ever wondered why you inherited your mothers ... Universities of Leeds and Dundee are one step closer ... DNA to create genetically unique offspring. , In a ... Carr and Dr Jonathan Hadden, together with Professor David ...
Other Biology News:Sea cucumbers fast track organ regrowth by healing their wounds 2
Homo sapiens similar to Cytosolic acyl coenzyme A thioester hydrolase Antigen: Peptide...
Cag-A (IgG) -Ab EIA Sample Size: 10 l...
... a protein ribonuclease inhibitor that noncovalently binds and ... is seen with RNase 1, T1, T2, H, ... human placental ribonuclease inhibitor in that it has ... not release active RNase in the absence of ...
... that has been shown to help maintain the ... by reverse transcription, in vitro RNA transcription, and ... tightly binds RNases in a 1:1 ratio. It ... as RNase A, RNase B, RNase C, and ...
Biology Products: